🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Fecal Microbiota Transplantation will be offered to eligible C. difficile p...
Status
Completed
Location
Stony Brook University Hospital
Start Date
2013-11
Trial ID
NCT03268213
Treatments Being Tested
This is a single site pilot trial will evaluate the feasibility and safety ...
Status
Recruiting
Location
University Health Network
Start Date
2026-06-02
Trial ID
NCT07509450
Treatments Being Tested
More and more people in Canada and around the world are severely (morbidly)...
Status
Completed
Location
University Health Network
Start Date
2017-03-01
Trial ID
NCT02970877
Fecal microbiota transplantation (FMT) is a treatment that restores the bal...
Status
Completed
Location
University of Alberta Hospital
Start Date
2019-03-21
Trial ID
NCT03806803
Treatments Being Tested
Title: The Role of Good Viruses in Inflammatory Bowel Disease Background A...
Status
Not Yet Recruiting
Location
Hvidovre Hospital
Start Date
2025-12-01
Trial ID
NCT07240181
Clostridioides difficile infection (CDI) is one of the most common hospital...
Status
Unknown
Location
Institute for Translational Medicine, University of Pécs
Start Date
2023-11-01
Trial ID
NCT04960306
Treatments Being Tested
FRESCO is a randomized, longitudinal, prospective, three arm, multicentre, ...
Status
Active Not Recruiting
Location
Jena University Hospital
Start Date
2023-01-31
Trial ID
NCT03843385
Treatments Being Tested
Carbapenemase-producing Enterobacteriaceae (CPE) are bacteria carried in th...
Status
Suspended
Location
William Osler Health System
Start Date
2019-03-22
Trial ID
NCT03802461
Treatments Being Tested
Every human harbors complex microbial communities (collectively, the human ...
Status
Unknown
Location
Women's college Research Institute
Start Date
2018-01-01
Trial ID
NCT03279224
Treatments Being Tested